Does Catalyst (CPRX) Have the Potential to Rally 36.22% as Wall Street Analysts Expect?

Catalyst Pharmaceutical (CPRX) closed the last trading session at $24.96, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $34 indicates a 36.2% upside potential.The average comprises eight short-term price targets ranging from a low of $31 to a high of $40, with a standard deviation of $2.98. While the lowest estimate indicates an increase of 24.2% from the current pri ...